Trump’s HHS Continues to Oppose Unilateral Drugmaker 340B Rebates in Kalderos Lawsuit

HHS filed a motion for summary judgement against Kalderos, the drug industry vendor behind Eli Lilly’s rebate proposal.
The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Trump Administration Opposes Unilateral Drugmaker 340B Rebates in First Legal Filing on Issue

HHS urged a federal court to dismiss lawsuits from Eli Lilly, Bristol Myers Squibb and Novartis seeking to implement 340B rebate models.
In the Trump administration’s first legal filing on drugmaker 340B rebates, the U.S. Department of Health and Human Services (HHS) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing 

The Senate Finance Committee pressed Mehmet Oz, known as "Dr. Oz," on whether he would oppose cuts to Medicaid as CMS administrator. Oliver Oz, his son who is marketed as having a leadership role at a 340B services company, sat behind him during the hearing.
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Sumitomo, J&J Announce 340B Refunds to Covered Entities

Sumitomo Pharma and Johnson & Johnson announced lists of drugs eligible for refunds.
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Senate Confirmation Hearing for Dr. Oz, Trump’s Pick to Lead CMS, Set for Tomorrow

The Senate Finance Committee announced it will hold a March 14 confirmation hearing on President Donald Trump's pick to lead CMS, Mehmet Oz.
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Recap of Recent Webinar: A Closer Look at Battles Over State 340B Contract Pharmacy Access Bills and Laws

340B Report's latest webinar overviewed contract pharmacy developments in state legislatures and the courts, plus how a dark money group has ramped up anti-340B ads.
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Sixth Hospital Sues HRSA Over J&J’s Controversial 340B Audit Requests

The University of Kansas Hospital sued HRSA in federal court for authorizing J&J to audit the hospital's 340B records.
The University of Kansas Hospital (UKHA) this week sued the federal government for authorizing Johnson & Johnson (J&J) to audit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

News Alert

Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference

340B Health leader Maureen Testoni criticizes a dark-money group's misleading ads during her talk at the 2025 340B Coalition Winter Conference in San Diego.
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Sagebrush Withdraws Lawsuit Against HRSA, Aims to Work with Agency on 340B Reinstatement Outside Court

Sagebrush filed a Feb. 21 motion to dismiss without prejudice its federal lawsuit against HRSA over 340B program eligibility.
Sagebrush Health, a Nevada-based STD clinic, has voluntarily dismissed its 340B lawsuit against the federal government—a move the clinic says [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Health Centers Host 340B Recertification Event In Lieu of HRSA’s Canceled Webinar

Health center advocates hosted a webinar on the 340B recertification process this year after HRSA canceled its annual webinar.
After the Health Resources and Services Administration (HRSA) canceled its annual 340B grantee recertification webinar amid disruptions from a federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live